🟠 Moderate Evidence
A large national cohort study has documented substantial gaps in kidney transplant access in the United States, revealing that nearly half of patients referred for evaluation never initiate the process, and only 19% ultimately reach the transplant waitlist. The research identifies geographic location, marital status, income, language, age, and transplant centre selection as key determinants of access disparities, suggesting that structural and socioeconomic factors—rather than medical suitability alone—govern transplantation pathways.
Key takeaways
- Nearly 50% of kidney transplant referrals never progress beyond initial referral; only 19% reach the waitlist
- Geographic residence, income level, marital status, language, age, and transplant centre affiliation significantly predict evaluation completion and waitlist placement
- Disparities suggest systemic barriers independent of medical candidacy, with implications for equitable access to definitive renal replacement therapy
- Findings highlight the need for targeted interventions to standardise evaluation processes and remove non-medical barriers
Study at a Glance
| Source | National cohort analysis (USA) |
| Study type | Observational cohort study |
| Population | Americans with kidney failure referred for transplant evaluation |
| Primary outcome | Completion of transplant evaluation; placement on waitlist |
| Country | United States |
Kidney Transplant Pathway Attrition: From Referral to Waitlist
Proportion of patients advancing at each stage of transplant evaluation, United States
Source: National kidney transplant cohort analysis, USA | Georgian Medical Journal News
Nearly half never initiate formal evaluation
The study found that 50% of patients referred for kidney transplant evaluation fail to initiate the process, representing a critical loss point in the transplantation pathway. This attrition occurs before formal medical assessment, suggesting that non-clinical barriers—such as logistical challenges, lack of awareness, or system navigation difficulties—may prevent eligible candidates from proceeding. The finding underscores that referral alone does not guarantee engagement with transplant centres.
Among those who do begin evaluation, progression to the waitlist remains limited. Only 19% of the original referral cohort ultimately achieve transplant listing, indicating that multiple decision points and potential barriers exist throughout the evaluation process. This low conversion rate raises concerns about whether current systems adequately support candidates through each stage, or whether systemic inefficiencies create unintended gatekeeping effects.
Geography, income, and social factors predict access
The research identified several non-medical characteristics that significantly influenced progression through transplant pathways. Geographic residence emerged as a key factor, with the implication that distance to centres, regional infrastructure differences, and availability of local transplant programmes affect candidacy outcomes. Healthcare access disparities driven by geography are well-documented across multiple conditions, but transplantation—requiring sustained multidisciplinary engagement—may be particularly susceptible to such variations.
Socioeconomic factors also shaped outcomes. Income level independently predicted both evaluation initiation and waitlist placement, suggesting that financial barriers—such as costs of repeated evaluations, time off work, or transportation—may disproportionately affect lower-income candidates. Similarly, marital status was associated with progression, possibly reflecting differences in social support networks and ability to navigate healthcare systems. Language emerged as a significant variable, indicating that non-English speakers may encounter communication or navigation challenges within transplant programmes.
Age and transplant centre selection further influenced pathways. Younger patients showed different progression patterns than older candidates, and the specific centre to which a patient was referred significantly predicted evaluation completion and listing. These centre-level differences suggest variability in programme protocols, staffing, efficiency, or cultural approaches to candidate evaluation—factors amenable to standardisation and quality improvement.
Implications for equity and clinical practice
The findings suggest that current US transplant systems inadvertently create barriers that filter out candidates based on demographics and social circumstance rather than medical suitability. Since kidney transplantation offers superior long-term survival and quality of life compared to dialysis, according to established clinical evidence, differential access represents a substantive health equity concern. Patients unable to navigate the evaluation system lose the opportunity for optimal treatment regardless of biological candidacy.
The study implicates systemic design issues rather than individual provider bias. Evaluation processes that are time-intensive, geographically dispersed, language-dependent, or financially burdensome will systematically disadvantage groups with fewer resources or social capital. Recognition of these patterns enables targeted interventions: streamlined evaluation protocols, telemedicine options to reduce geographic barriers, multilingual staff support, and financial assistance programmes could reduce attrition and increase equitable access.
Centre-level variation in outcomes also suggests opportunity for benchmarking and shared learning. If certain transplant programmes achieve higher evaluation completion or listing rates despite similar patient populations, those centres’ protocols and practices may merit adoption elsewhere. Quality improvement initiatives focused on standardising best practices and removing non-medical barriers could meaningfully shift the transplant pathway landscape.
Broader context and future directions
Kidney disease affects approximately 37 million adults in the United States, according to the National Kidney Foundation, yet transplantation remains vastly under-utilised as a treatment modality. The gap between referral and successful listing documented in this study represents lost therapeutic opportunity on a population scale. Given that transplant recipients experience superior clinical and economic outcomes compared to dialysis patients, improving referral-to-listing conversion rates should be a public health priority.
Future research should examine specific mechanisms of attrition—for example, whether candidates withdraw voluntarily, are discontinued by centres, or become lost to follow-up—and explore interventions tested in pilot programmes. Qualitative studies capturing patient experience and centre-level factors could illuminate modifiable barriers. Additionally, monitoring these metrics as part of routine centre accreditation and quality reporting could create accountability for equitable evaluation practices.
Only 19% of kidney transplant referrals progress to waitlist placement, with geographic location, income, marital status, language, age, and transplant centre affiliation significantly predicting access to this life-extending therapy.
— National kidney transplant cohort study (2026)
What this means
Frequently asked questions
Why do so many kidney transplant candidates never begin evaluation?
The study does not delineate specific reasons for attrition, but the identified predictive factors—geography, income, language, marital status—suggest that logistical, financial, and navigational barriers prevent engagement. Candidates may lack awareness of the process, face transportation difficulties, experience communication challenges, or encounter informal gatekeeping by healthcare providers. Qualitative follow-up research is needed to understand whether attrition reflects patient choice, system barriers, or both.
Is a kidney transplant always better than dialysis?
For most eligible patients, transplantation from either a living or deceased donor offers superior survival, quality of life, and economic outcomes compared to long-term dialysis. However, individual medical factors—age, comorbidities, life expectancy—influence suitability. Transplantation is not universally appropriate, but the current study shows that access barriers, rather than medical contraindications, explain most non-progression. Candidates who are medically suitable should have equitable opportunity to pursue transplantation.
What can be done to reduce attrition in the transplant pathway?
Interventions may include: streamlined evaluation protocols requiring fewer visits; telemedicine consultations to reduce travel burden; multilingual staff and materials; financial assistance with evaluation costs; proactive patient communication and navigation support; and centre-level quality metrics tracking evaluation completion by demographic group. Sharing best practices between centres and removing unnecessary procedural steps could improve access. Policy changes—such as payment reform or expanded funding for transplant programmes in under-resourced regions—may also help.
The disparities documented in this national cohort study underscore that access to kidney transplantation—a clinically and economically superior treatment—remains unevenly distributed across the US population. Addressing these gaps requires systemic attention: simplifying evaluation processes, removing financial barriers, and investing in equitable programme infrastructure. As transplantation capacity and donor availability remain limited, ensuring that evaluation systems themselves do not further restrict access to those already marginalised is both an ethical imperative and a public health necessity.
Source: Nearly half of kidney transplant patients never even get started
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
